5-{5-[3,4-Dihydroxy-6-methyl-5-(4,5,6-trihydroxy-3-hydroxymethyl-cyclohex-2-enylamino)-tetrahydro-pyran-2-yloxy]-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy}-6-hydroxymethyl-tetrahydro-pyran-2,3,4-triol

ID: ALA1566

Chembl Id: CHEMBL1566

Cas Number: 56180-94-0

PubChem CID: 444254

Max Phase: Approved

First Approval: 1995

Molecular Formula: C25H43NO18

Molecular Weight: 645.61

Molecule Type: Oligosaccharide

Associated Items:

Names and Identifiers

Synonyms: Acarbose | BAY G 5421 | BAY-G-5421 | NSC-758915 | acarbose|Prandase|Glucobay|Precose|BAY-g 5421|Bay-g-5421|Beta-Acarbose|56180-94-0|Bay g 5421|CHEMBL1566|Alpha-Acarbose|Glucor|CAS-56180-94-0|Arcabose|Ascarbose|1agm|1ukt|NCGC00159353-02|QPS|Acarbose, >=95%|SCHEMBL16848|GTPL6791|CHEBI:94035|BCPP000442|HMS3269L19|HMS3413P19|HMS3677P19|HMS3713B18|Tox21_111597|BDBM50333465|s1271|AKOS024457233|Tox21_111597_1|BCP9000224|CCG-220568|NCGC00160515-02|NS00001516|AB01274765-01|AB01274765_02|A830944|EN300-270Show More

Trade Names(3): Acarbose | Glucobay | Precose

Canonical SMILES:  C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-/m1/s1

Standard InChI Key:  XUFXOAAUWZOOIT-SXARVLRPSA-N

Alternative Forms

  1. Parent:

    ALA1566

    ACARBOSE

Associated Targets(Human)

GANAB Tchem Neutral alpha-glucosidase AB (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGAM Tclin Maltase-glucoamylase (654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AMY1A Salivary alpha-amylase (100 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A1 Tchem Solute carrier family 22 member 1 (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GAA Tclin Lysosomal alpha-glucosidase (35701 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR2 Tchem Angiotensin II type 2 (AT-2) receptor (2549 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BDKRB2 Tclin Bradykinin B2 receptor (3970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR2 Tchem C-C chemokine receptor type 2 (5628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR4 Tclin C-C chemokine receptor type 4 (2819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR1 Tchem Interleukin-8 receptor A (2256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR2 Tchem Interleukin-8 receptor B (3491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCKAR Tclin Cholecystokinin A receptor (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2A6 Tchem Cytochrome P450 2A6 (2861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC3R Tchem Melanocortin receptor 3 (5659 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC4R Tclin Melanocortin receptor 4 (10016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC5R Tchem Melanocortin receptor 5 (4283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM5 Tclin Muscarinic acetylcholine receptor M5 (4677 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY1R Tchem Neuropeptide Y receptor type 1 (5019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY2R Tchem Neuropeptide Y receptor type 2 (3731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CASP1 Tchem Caspase-1 (6235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSG Tchem Cathepsin G (2304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ELANE Tclin Leukocyte elastase (8173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPP3CA Tchem Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform (1831 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPRC Tchem Leukocyte common antigen (2317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR2 Tchem Neurokinin 2 receptor (3341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXAS1 Tchem Thromboxane-A synthase (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VIPR1 Tchem Vasoactive intestinal polypeptide receptor 1 (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO2B1 Tchem Solute carrier organic anion transporter family member 2B1 (580 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (2517 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 (2672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WRL68 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR7 Tclin Serotonin 7 (5-HT7) receptor (5576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABBR1 Tclin GABA-B receptor 1 (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GIPR Tchem Gastric inhibitory polypeptide receptor (542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCKBR Tclin Cholecystokinin B receptor (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GCGR Tclin Glucagon receptor (2563 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRB Tclin Endothelin receptor ET-B (1928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BDKRB1 Tchem Bradykinin B1 receptor (1859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRHR2 Tchem Corticotropin releasing factor receptor 2 (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTSR1 Tchem Neurotensin receptor 1 (1525 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gaa Acidic alpha-glucosidase (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Si Sucrase-isomaltase (908 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGL Glycogen debranching enzyme (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAL12 Alpha-glucosidase MAL12 (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lct Lactase-glycosylceramidase (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-glucosidase (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAL62 Alpha-glucosidase MAL62 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Insr Insulin receptor (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTC4S Leukotriene C4 synthase (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15 Arachidonate 15-lipoxygenase (2064 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos1 Nitric-oxide synthase, brain (2987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Progesterone receptor (1742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Angiotensin-converting enzyme (2863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1a Serotonin 1a (5-HT1a) receptor (8655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1b Serotonin 1b (5-HT1b) receptor (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Serotonin 4 (5-HT4) receptor (2870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gaa Lysosomal alpha-glucosidase (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AMY2 Pancreatic alpha-amylase (211 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMA1 Oligo-1,6-glucosidase (218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NRK (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1c Voltage-gated L-type calcium channel alpha-1C subunit (1321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate (NMDA) receptor subunit zeta 1 (2166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabra1 GABA receptor alpha-1 subunit (2848 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1b Voltage-gated N-type calcium channel alpha-1B subunit (471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgs1 Cyclooxygenase-1 (1373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: YesChemical Probe: NoParenteral: No
Molecule Type: OligosaccharideTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: YesProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 645.61Molecular Weight (Monoisotopic): 645.2480AlogP: -8.56#Rotatable Bonds: 9
Polar Surface Area: 321.17Molecular Species: NEUTRALHBA: 19HBD: 14
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.23CX Basic pKa: 7.03CX LogP: -7.61CX LogD: -7.77
Aromatic Rings: 0Heavy Atoms: 44QED Weighted: 0.10Np Likeness Score: 1.83

References

1. Sharon A, Pratap R, Tripathi B, Srivastava AK, Maulik PR, Ram VJ..  (2005)  Biaryls and heterobiaryls as alpha-glucosidase and protein tyrosine phosphatase inhibitors.,  15  (5): [PMID:15713383] [10.1016/j.bmcl.2005.01.036]
2. Seo WD, Kim JH, Kang JE, Ryu HW, Curtis-Long MJ, Lee HS, Yang MS, Park KH..  (2005)  Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.,  15  (24): [PMID:16202584] [10.1016/j.bmcl.2005.08.087]
3. Pandey J, Dwivedi N, Singh N, Srivastava AK, Tamarkar A, Tripathi RP..  (2007)  Diastereoselective synthesis of glycosylated prolines as alpha-glucosidase inhibitors and organocatalyst in asymmetric aldol reaction.,  17  (5): [PMID:17188491] [10.1016/j.bmcl.2006.12.002]
4. Xu HW, Dai GF, Liu GZ, Wang JF, Liu HM..  (2007)  Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors.,  15  (12): [PMID:17428667] [10.1016/j.bmc.2007.03.063]
5. Li W, Wei K, Fu H, Koike K..  (2007)  Structure and absolute configuration of clerodane diterpene glycosides and a rearranged cadinane sesquiterpene glycoside from the stems of Tinospora sinensis.,  70  (12): [PMID:18020421] [10.1021/np070367i]
6. Hari Babu T, Rama Subba Rao V, Tiwari AK, Suresh Babu K, Srinivas PV, Ali AZ, Madhusudana Rao J..  (2008)  Synthesis and biological evaluation of novel 8-aminomethylated oroxylin A analogues as alpha-glucosidase inhibitors.,  18  (5): [PMID:18255289] [10.1016/j.bmcl.2008.01.055]
7. Luo JG, Ma L, Kong LY..  (2008)  New triterpenoid saponins with strong alpha-glucosidase inhibitory activity from the roots of Gypsophila oldhamiana.,  16  (6): [PMID:18194870] [10.1016/j.bmc.2007.12.053]
8. Tiwari AK, Kumbhare RM, Agawane SB, Ali AZ, Kumar KV..  (2008)  Reduction in post-prandial hyperglycemic excursion through alpha-glucosidase inhibition by beta-acetamido carbonyl compounds.,  18  (14): [PMID:18539458] [10.1016/j.bmcl.2008.05.088]
9. Park H, Hwang KY, Kim YH, Oh KH, Lee JY, Kim K..  (2008)  Discovery and biological evaluation of novel alpha-glucosidase inhibitors with in vivo antidiabetic effect.,  18  (13): [PMID:18524587] [10.1016/j.bmcl.2008.05.056]
10. Kouam SF, Khan SN, Krohn K, Ngadjui BT, Kapche DG, Yapna DB, Zareem S, Moustafa AM, Choudhary MI..  (2006)  Alpha-glucosidase inhibitory anthranols, kenganthranols A-C, from the stem bark of Harungana madagascariensis.,  69  (2): [PMID:16499321] [10.1021/np050407n]
11. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P..  (2008)  Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.,  51  (19): [PMID:18788725] [10.1021/jm8003152]
12. Ma CM, Hattori M, Daneshtalab M, Wang L..  (2008)  Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: potent alpha-glucosidase inhibitors.,  51  (19): [PMID:18783210] [10.1021/jm800621x]
13. Washburn WN..  (2009)  Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.,  52  (7): [PMID:19243175] [10.1021/jm8013019]
14. Prabhakar Reddy P, Tiwari AK, Ranga Rao R, Madhusudhana K, Rama Subba Rao V, Ali AZ, Suresh Babu K, Madhusudana Rao J..  (2009)  New Labdane diterpenes as intestinal alpha-glucosidase inhibitor from antihyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes.,  19  (9): [PMID:19332371] [10.1016/j.bmcl.2009.03.045]
15. Hu LH, Zou HB, Gong JX, Li HB, Yang LX, Cheng W, Zhou CX, Bai H, Guéritte F, Zhao Y..  (2005)  Synthesis and biological evaluation of a natural ester sintenin and its synthetic analogues.,  68  (3): [PMID:15787433] [10.1021/np0496441]
16. Kuriyama C, Kamiyama O, Ikeda K, Sanae F, Kato A, Adachi I, Imahori T, Takahata H, Okamoto T, Asano N..  (2008)  In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.,  16  (15): [PMID:18595718] [10.1016/j.bmc.2008.06.026]
17. Lo Piparo E, Scheib H, Frei N, Williamson G, Grigorov M, Chou CJ..  (2008)  Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.,  51  (12): [PMID:18507367] [10.1021/jm800115x]
18. Zhang H, Xue J, Wu P, Xu L, Xie H, Wei X..  (2009)  Polyoxygenated methyl cyclohexanoids from a terrestrial ampelomyces fungus.,  72  (2): [PMID:19193024] [10.1021/np800667e]
19. Bisht SS, Fatima S, Tamrakar AK, Rahuja N, Jaiswal N, Srivastava AK, Tripathi RP..  (2009)  Synthetic studies in butenonyl C-glycosides: Preparation of polyfunctional alkanonyl glycosides and their enzyme inhibitory activity.,  19  (10): [PMID:19362832] [10.1016/j.bmcl.2009.03.136]
20. Lee SS, Lin YS, Chen CK..  (2009)  Three adducts of butenolide and apigenin glycoside from the leaves of Machilus japonica.,  72  (7): [PMID:19719245] [10.1021/np9000653]
21. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD..  (2010)  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.,  53  (3): [PMID:20070106] [10.1021/jm901371v]
22. Ferreira SB, Sodero AC, Cardoso MF, Lima ES, Kaiser CR, Silva FP, Ferreira VF..  (2010)  Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.,  53  (6): [PMID:20170190] [10.1021/jm901265h]
23. Raju BC, Tiwari AK, Kumar JA, Ali AZ, Agawane SB, Saidachary G, Madhusudana K..  (2010)  alpha-Glucosidase inhibitory antihyperglycemic activity of substituted chromenone derivatives.,  18  (1): [PMID:19932027] [10.1016/j.bmc.2009.10.047]
24. Li W, Fu H, Bai H, Sasaki T, Kato H, Koike K..  (2009)  Triterpenoid saponins from Rubus ellipticus var. obcordatus.,  72  (10): [PMID:19795885] [10.1021/np900237a]
25. Lin HC, Lee SS..  (2010)  Proanthocyanidins from the leaves of Machilus philippinensis.,  73  (8): [PMID:20568785] [10.1021/np1002274]
26. PubChem BioAssay data set, 
27. Obach RS, Lombardo F, Waters NJ..  (2008)  Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.,  36  (7): [PMID:18426954] [10.1124/dmd.108.020479]
28. Natori Y, Imahori T, Murakami K, Yoshimura Y, Nakagawa S, Kato A, Adachi I, Takahata H..  (2011)  The synthesis and biological evaluation of 1-C-alkyl-L-arabinoiminofuranoses, a novel class of α-glucosidase inhibitors.,  21  (2): [PMID:21185187] [10.1016/j.bmcl.2010.11.112]
29. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE..  (2011)  Prediction of drug intestinal absorption by new linear and non-linear QSPR.,  46  (1): [PMID:21112128] [10.1016/j.ejmech.2010.11.005]
30. Xie W, Tanabe G, Akaki J, Morikawa T, Ninomiya K, Minematsu T, Yoshikawa M, Wu X, Muraoka O..  (2011)  Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors.,  19  (6): [PMID:21345683] [10.1016/j.bmc.2011.01.052]
31. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A..  (2010)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.,  23  (1): [PMID:20014752] [10.1021/tx900326k]
32. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF..  (2004)  Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.,  (4): [PMID:16472241] [10.2174/1570163043334794]
33. Unpublished dataset, 
34. Park S, Hyun S, Do SI, Yu J..  (2011)  Selective α-glucosidase substrates and inhibitors containing short aromatic peptidyl moieties.,  21  (8): [PMID:21397496] [10.1016/j.bmcl.2011.02.062]
35. Xie W, Tanabe G, Matsuoka K, Amer MF, Minematsu T, Wu X, Yoshikawa M, Muraoka O..  (2011)  Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor.,  19  (7): [PMID:21420866] [10.1016/j.bmc.2011.02.028]
36. Brindis F, Rodríguez R, Bye R, González-Andrade M, Mata R..  (2011)  (Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.,  74  (3): [PMID:20879744] [10.1021/np100447a]
37. Tanabe G, Otani T, Cong W, Minematsu T, Ninomiya K, Yoshikawa M, Muraoka O..  (2011)  Biological evaluation of 3'-O-alkylated analogs of salacinol, the role of hydrophobic alkyl group at 3' position in the side chain on the α-glucosidase inhibitory activity.,  21  (10): [PMID:21454075] [10.1016/j.bmcl.2011.02.109]
38. Chan HH, Hwang TL, Reddy MV, Li DT, Qian K, Bastow KF, Lee KH, Wu TS..  (2011)  Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.,  74  (4): [PMID:21417387] [10.1021/np100851s]
39. Jones K, Sim L, Mohan S, Kumarasamy J, Liu H, Avery S, Naim HY, Quezada-Calvillo R, Nichols BL, Pinto BM, Rose DR..  (2011)  Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase.,  19  (13): [PMID:21669536] [10.1016/j.bmc.2011.05.033]
40. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, 
41. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W..  (2011)  FDA-approved drug labeling for the study of drug-induced liver injury.,  16  (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007]
42. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W..  (2011)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).,  (12): [PMID:22194678] [10.1371/journal.pcbi.1002310]
43. Wan C, Yuan T, Li L, Kandhi V, Cech NB, Xie M, Seeram NP..  (2012)  Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems.,  22  (1): [PMID:22079755] [10.1016/j.bmcl.2011.10.073]
44. Morikawa T, Chaipech S, Matsuda H, Hamao M, Umeda Y, Sato H, Tamura H, Kon'i H, Ninomiya K, Yoshikawa M, Pongpiriyadacha Y, Hayakawa T, Muraoka O..  (2012)  Antidiabetogenic oligostilbenoids and 3-ethyl-4-phenyl-3,4-dihydroisocoumarins from the bark of Shorea roxburghii.,  20  (2): [PMID:22209731] [10.1016/j.bmc.2011.11.067]
45. Worawalai W, Rattanangkool E, Vanitcha A, Phuwapraisirisan P, Wacharasindhu S..  (2012)  Concise synthesis of (+)-conduritol F and inositol analogues from naturally available (+)-proto-quercitol and their glucosidase inhibitory activity.,  22  (4): [PMID:22290077] [10.1016/j.bmcl.2012.01.007]
46. Escandón-Rivera S, González-Andrade M, Bye R, Linares E, Navarrete A, Mata R..  (2012)  α-glucosidase inhibitors from Brickellia cavanillesii.,  75  (5): [PMID:22587572] [10.1021/np300204p]
47. Omar R, Li L, Yuan T, Seeram NP..  (2012)  α-Glucosidase inhibitory hydrolyzable tannins from Eugenia jambolana seeds.,  75  (8): [PMID:22867049] [10.1021/np300417q]
48. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
49. Lin HC, Lee SS..  (2012)  Dibenzocycloheptanoids from the leaves of Cinnamomum subavenium.,  75  (10): [PMID:23025417] [10.1021/np300402k]
50. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P..  (2012)  Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.,  55  (10): [PMID:22541068] [10.1021/jm300212s]
51. Kato A, Hayashi E, Miyauchi S, Adachi I, Imahori T, Natori Y, Yoshimura Y, Nash RJ, Shimaoka H, Nakagome I, Koseki J, Hirono S, Takahata H..  (2012)  α-1-C-butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia.,  55  (23): [PMID:23106358] [10.1021/jm301304e]
52. Çavdar H, Talaz O, Ekinci D..  (2012)  Synthesis of novel mono and bis-indole conduritol derivatives and their α/β-glycosidase inhibitory effects.,  22  (24): [PMID:23137433] [10.1016/j.bmcl.2012.10.038]
53. Zhang B, Chen T, Chen Z, Wang M, Zheng D, Wu J, Jiang X, Li X..  (2012)  Synthesis and anti-hyperglycemic activity of hesperidin derivatives.,  22  (23): [PMID:23067551] [10.1016/j.bmcl.2012.09.049]
54. Patil VS, Nandre KP, Ghosh S, Rao VJ, Chopade BA, Bhosale SV, Bhosale SV..  (2012)  Synthesis and glycosidase inhibitory activity of novel (2-phenyl-4H-benzopyrimedo[2,1-b]-thiazol-4-yliden)acetonitrile derivatives.,  22  (23): [PMID:23102653] [10.1016/j.bmcl.2012.10.025]
55. Sancheti S, Sancheti S, Bafna M, Seo S.  (2011)  2,4,6-Trihydroxybenzaldehyde as a potent antidiabetic agent alleviates postprandial hyperglycemia in normal and diabetic rats,  20  (8): [10.1007/s00044-010-9461-8]
56. Misra S, Pandeya KB, Tiwari AK, Ali AZ, Saradamani T, Agawane SB, Madhusudana K.  (2011)  Antihyperglycemic, -glucosidase inhibitory and DPPH free radical scavenging activity of 5-bromosalicylaldehyde and schiff bases,  20  (9): [10.1007/s00044-010-9377-3]
57. Chang X, Kang W.  (2012)  Antioxidant and -glucosidase inhibitory compounds from Pimpinella candolleana Wight et Arn.,  21  (12): [10.1007/s00044-012-9974-4]
58. Zhu X, Ye X, Yuan L, Ding Y, Zhang B, Li X.  (2012)  Synthesis and hypoglycemic activity evaluation of 7-alkoxyl-rhein,  21  (4): [10.1007/s00044-010-9511-2]
59. Takahashi T, Miyazawa M.  (2012)  Synthesis and structureactivity relationships of serotonin derivatives effect on -glucosidase inhibition,  21  (8): [10.1007/s00044-011-9699-9]
60. Ranga Rao R, Tiwari AK, Prabhakar Reddy P, Suresh Babu K, Suresh G, Ali AZ, Madhusudana K, Agawane SB, Badrinarayan P, Narahari Sastry G, Madhusudana Rao J.  (2012)  Synthesis of antihyperglycemic, -glucosidase inhibitory, and DPPH free radical scavenging furanochalcones,  21  (6): [10.1007/s00044-011-9583-7]
61. Kang W, Song Y, Zhang L.  (2011)  -Glucosidase inhibitory and antioxidant properties and antidiabetic activity of Hypericum ascyron L.,  20  (7): [10.1007/s00044-010-9391-5]
62. Raj CGD, Sarojini BK, Khan MTH, Raghavendra R.  (2013)  In vivo antidiabetic activity and in silico studies on adenosine monophosphate-activated protein kinase (AMPK) of (2E,5E)-2,5-bis(4-hydroxy-3-methoxybenzylidene) cyclopentanone,  22  (5): [10.1007/s00044-012-0237-1]
63. Patil VS, Nandre KP, Ghosh S, Rao VJ, Chopade BA, Sridhar B, Bhosale SV, Bhosale SV..  (2013)  Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-one.,  59  [PMID:23262035] [10.1016/j.ejmech.2012.11.020]
64. Fushimi N, Teranishi H, Shimizu K, Yonekubo S, Ohno K, Miyagi T, Itoh F, Shibazaki T, Tomae M, Ishikawa-Takemura Y, Nakabayashi T, Kamada N, Yamauchi Y, Kobayashi S, Isaji M..  (2013)  Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-D-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1).,  21  (3): [PMID:23273606] [10.1016/j.bmc.2012.11.041]
65. Sultan S, Choudhary MI, Khan SN, Fatima U, Atif M, Ali RA, Rahman AU, Fatmi MQ..  (2013)  Fungal transformation of cedryl acetate and α-glucosidase inhibition assay, quantum mechanical calculations and molecular docking studies of its metabolites.,  62  [PMID:23455027] [10.1016/j.ejmech.2013.01.036]
66. Guerreiro LR, Carreiro EP, Fernandes L, Cardote TA, Moreira R, Caldeira AT, Guedes RC, Burke AJ..  (2013)  Five-membered iminocyclitol α-glucosidase inhibitors: synthetic, biological screening and in silico studies.,  21  (7): [PMID:23419323] [10.1016/j.bmc.2013.01.030]
67. Bian X, Wang Q, Ke C, Zhao G, Li Y..  (2013)  A new series of N2-substituted-5-(p-toluenesulfonylamino)phthalimide analogues as α-glucosidase inhibitors.,  23  (7): [PMID:23466232] [10.1016/j.bmcl.2013.02.011]
68. Narender T, Madhur G, Jaiswal N, Agrawal M, Maurya CK, Rahuja N, Srivastava AK, Tamrakar AK..  (2013)  Synthesis of novel triterpene and N-allylated/N-alkylated niacin hybrids as α-glucosidase inhibitors.,  63  [PMID:23474902] [10.1016/j.ejmech.2013.01.053]
69. Uvarani C, Sankaran M, Jaivel N, Chandraprakash K, Ata A, Mohan PS..  (2013)  Bioactive dimeric carbazole alkaloids from Murraya koenigii.,  76  (6): [PMID:23691929] [10.1021/np300464t]
70. Hano C, Renouard S, Molinié R, Corbin C, Barakzoy E, Doussot J, Lamblin F, Lainé E..  (2013)  Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity.,  23  (10): [PMID:23583514] [10.1016/j.bmcl.2013.03.029]
71. Wan LS, Min QX, Wang YL, Yue YD, Chen JC..  (2013)  Xanthone glycoside constituents of Swertia kouitchensis with α-glucosidase inhibitory activity.,  76  (7): [PMID:23805995] [10.1021/np400082g]
72. Bian X, Fan X, Ke C, Luan Y, Zhao G, Zeng A..  (2013)  Synthesis and α-glucosidase inhibitory activity evaluation of N-substituted aminomethyl-β-d-glucopyranosides.,  21  (17): [PMID:23810673] [10.1016/j.bmc.2013.06.002]
73. Rattanangkool E, Kittikhunnatham P, Damsud T, Wacharasindhu S, Phuwapraisirisan P..  (2013)  Quercitylcinnamates, a new series of antidiabetic bioconjugates possessing α-glucosidase inhibition and antioxidant.,  66  [PMID:23811091] [10.1016/j.ejmech.2013.05.047]
74. Fatmawati S, Kondo R, Shimizu K..  (2013)  Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors.,  23  (21): [PMID:24070782] [10.1016/j.bmcl.2013.08.084]
75. Yan RY, Wang HQ, Liu C, Kang J, Chen RY..  (2013)  α-Glucosidase-inhibitory iminosugars from the leaves of Suregada glomerulata.,  21  (21): [PMID:23993676] [10.1016/j.bmc.2013.07.048]
76. Unpublished dataset, 
77. Unpublished dataset, 
78. Unpublished dataset, 
79. Chinthala Y, Kumar Domatti A, Sarfaraz A, Singh SP, Kumar Arigari N, Gupta N, Satya SK, Kotesh Kumar J, Khan F, Tiwari AK, Paramjit G..  (2013)  Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.,  70  [PMID:24177357] [10.1016/j.ejmech.2013.10.005]
80. Khan MS, Munawar MA, Ashraf M, Alam U, Ata A, Asiri AM, Kousar S, Khan MA..  (2014)  Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors.,  22  (3): [PMID:24398385] [10.1016/j.bmc.2013.12.024]
81. Wang QQ, Cheng N, Yi WB, Peng SM, Zou XQ..  (2014)  Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.,  22  (5): [PMID:24508143] [10.1016/j.bmc.2014.01.038]
82. Thao NP, Luyen BT, Tai BH, Yang SY, Jo SH, Cuong NX, Nam NH, Kwon YI, Minh CV, Kim YH..  (2014)  Rat intestinal sucrase inhibition of constituents from the roots of Rosa rugosa Thunb.,  24  (4): [PMID:24461297] [10.1016/j.bmcl.2013.12.098]
83. Kim T, Choi HJ, Eom SH, Lee J, Kim TH..  (2014)  Potential α-glucosidase inhibitors from thermal transformation of (+)-catechin.,  24  (6): [PMID:24491460] [10.1016/j.bmcl.2014.01.027]
84. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R..  (2004)  [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs].,  28  (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2]
85. PubChem BioAssay data set, 
86. PubChem BioAssay data set, 
87. Worawalai W, Wacharasindhu S, Phuwapraisirisan P.  (2012)  Synthesis of new N-substituted aminoquercitols from naturally available (+)-proto-quercitol and their -glucosidase inhibitory activity,  (11): [10.1039/C2MD20227A]
88. Ma K, Han J, Bao L, Wei T, Liu H..  (2014)  Two sarcoviolins with antioxidative and α-glucosidase inhibitory activity from the edible mushroom Sarcodon leucopus collected in Tibet.,  77  (4): [PMID:24645629] [10.1021/np401026b]
89. Khan KM, Rahim F, Wadood A, Kosar N, Taha M, Lalani S, Khan A, Fakhri MI, Junaid M, Rehman W, Khan M, Perveen S, Sajid M, Choudhary MI..  (2014)  Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.,  81  [PMID:24844449] [10.1016/j.ejmech.2014.05.010]
90. Dhumaskar KL, Meena SN, Ghadi SC, Tilve SG..  (2014)  Graphite catalyzed solvent free synthesis of dihydropyrimidin-2(1H)-ones/thiones and their antidiabetic activity.,  24  (13): [PMID:24835627] [10.1016/j.bmcl.2014.04.099]
91. Khan M, Yousaf M, Wadood A, Junaid M, Ashraf M, Alam U, Ali M, Arshad M, Hussain Z, Khan KM..  (2014)  Discovery of novel oxindole derivatives as potent α-glucosidase inhibitors.,  22  (13): [PMID:24825482] [10.1016/j.bmc.2014.04.033]
92. Liu Q, Yang QM, Hu HJ, Yang L, Yang YB, Chou GX, Wang ZT..  (2014)  Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis.,  77  (7): [PMID:24955889] [10.1021/np500150f]
93. Ponnam D, Shilpi S, Srinivas KV, Suiab L, Alam S, Amtul Z, Arigari NK, Jonnala KK, Siddiqui L, Dubey V, Tiwari AK, Balasubramanian S, Khan F..  (2014)  Synthesis of cyclic 1,9-acetal derivatives of forskolin and their bioactivity evaluation.,  87  [PMID:25305717] [10.1016/j.ejmech.2014.10.013]
94. Kashtoh H, Hussain S, Khan A, Saad SM, Khan JA, Khan KM, Perveen S, Choudhary MI..  (2014)  Oxadiazoles and thiadiazoles: novel α-glucosidase inhibitors.,  22  (19): [PMID:25151088] [10.1016/j.bmc.2014.07.032]
95. Natori Y, Sakuma T, Yoshimura Y, Kinami K, Hirokami Y, Sato K, Adachi I, Kato A, Takahata H..  (2014)  Synthesis and biological evaluation of α-1-C-4'-arylbutyl-L-arabinoiminofuranoses, a new class of α-glucosidase inhibitors.,  24  (15): [PMID:24973028] [10.1016/j.bmcl.2014.06.001]
96. Worawalai W, Wacharasindhu S, Phuwapraisirisan P..  (2014)  Amine-linked diquercitols as new α-glucosidase inhibitors.,  24  (23): [PMID:25451999] [10.1016/j.bmcl.2014.09.064]
97. Luyen BT, Tai BH, Thao NP, Yang SY, Cuong NM, Kwon YI, Jang HD, Kim YH..  (2014)  A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.,  24  (17): [PMID:25127165] [10.1016/j.bmcl.2014.07.057]
98. Wang K, Bao L, Qi Q, Zhao F, Ma K, Pei Y, Liu H..  (2015)  Erinacerins C-L, isoindolin-1-ones with α-glucosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus.,  78  (1): [PMID:25565282] [10.1021/np5004388]
99. Han K, Li Y, Zhang Y, Teng Y, Ma Y, Wang M, Wang R, Xu W, Yao Q, Zhang Y, Qin H, Sun H, Yu P..  (2015)  Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.,  25  (7): [PMID:25759031] [10.1016/j.bmcl.2015.02.031]
100. Taha M, Ismail NH, Lalani S, Fatmi MQ, Atia-Tul-Wahab, Siddiqui S, Khan KM, Imran S, Choudhary MI..  (2015)  Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies.,  92  [PMID:25585009] [10.1016/j.ejmech.2015.01.009]
101. Chinthala Y, Thakur S, Tirunagari S, Chinde S, Domatti AK, Arigari NK, K V N S S, Alam S, Jonnala KK, Khan F, Tiwari A, Grover P..  (2015)  Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.,  93  [PMID:25743216] [10.1016/j.ejmech.2015.02.027]
102. Calcatierra V, López Ó, Fernández-Bolaños JG, Plata GB, Padrón JM..  (2015)  Phenolic thio- and selenosemicarbazones as multi-target drugs.,  94  [PMID:25752525] [10.1016/j.ejmech.2015.02.037]
103. Sriyatep T, Siridechakorn I, Maneerat W, Pansanit A, Ritthiwigrom T, Andersen RJ, Laphookhieo S..  (2015)  Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.,  78  (2): [PMID:25651042] [10.1021/np5008476]
104. Worawalai W, Wacharasindhu S, Phuwapraisirisan P..  (2015)  N-Arylmethylaminoquercitols, a new series of effective antidiabetic agents having α-glucosidase inhibition and antioxidant activity.,  25  (12): [PMID:25959812] [10.1016/j.bmcl.2015.04.033]
105. Honda T, Takakusa H, Murai T, Izumi T..  (2013)  Tissue distribution and identification of radioactivity components at elimination phase after oral administration of [¹⁴C]CS-1036, an α-amylase inhibitor, to rats.,  41  (5): [PMID:23454829] [10.1124/dmd.112.050617]
106. Rivera-Chávez J, Figueroa M, González Mdel C, Glenn AE, Mata R..  (2015)  α-Glucosidase Inhibitors from a Xylaria feejeensis Associated with Hintonia latiflora.,  78  (4): [PMID:25706243] [10.1021/np500897y]
107. Gao C, Han L, Zheng D, Jin H, Gai C, Wang J, Zhang H, Zhang L, Fu H..  (2015)  Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.,  78  (4): [PMID:25739048] [10.1021/np500746n]
108. Liu Y, Yang Q, Xia G, Huang H, Li H, Ma L, Lu Y, He L, Xia X, She Z..  (2015)  Polyketides with α-Glucosidase Inhibitory Activity from a Mangrove Endophytic Fungus, Penicillium sp. HN29-3B1.,  78  (8): [PMID:26230970] [10.1021/np500885f]
109. Wang K, Bao L, Xiong W, Ma K, Han J, Wang W, Yin W, Liu H..  (2015)  Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.,  78  (8): [PMID:26287401] [10.1021/acs.jnatprod.5b00331]
110. Su ZR, Fan SY, Shi WG, Zhong BH..  (2015)  Discovery of xanthine oxidase inhibitors and/or α-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of apigenin.,  25  (14): [PMID:26022844] [10.1016/j.bmcl.2015.05.016]
111. Chang CC, Ho SL, Lee SS..  (2015)  Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.,  23  (13): [PMID:25999202] [10.1016/j.bmc.2015.04.053]
112. Taha M, Ismail NH, Imran S, Rokei MQ, Saad SM, Khan KM..  (2015)  Synthesis of new oxadiazole derivatives as α-glucosidase inhibitors.,  23  (15): [PMID:26183542] [10.1016/j.bmc.2015.06.060]
113. Zhao XR, Huo XK, Dong PP, Wang C, Huang SS, Zhang BJ, Zhang HL, Deng S, Liu KX, Ma XC..  (2015)  Inhibitory Effects of Highly Oxygenated Lanostane Derivatives from the Fungus Ganoderma lucidum on P-Glycoprotein and α-Glucosidase.,  78  (8): [PMID:26222905] [10.1021/acs.jnatprod.5b00132]
114. Doddaramappa SD, Lokanatha Rai KM, Srikantamurthy N, Chandra, Chethan J..  (2015)  Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.,  25  (17): [PMID:26152425] [10.1016/j.bmcl.2015.06.050]
115. Sun H, Li Y, Zhang X, Lei Y, Ding W, Zhao X, Wang H, Song X, Yao Q, Zhang Y, Ma Y, Wang R, Zhu T, Yu P..  (2015)  Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.,  25  (20): [PMID:26351039] [10.1016/j.bmcl.2015.08.059]
116. Barakat A, Islam MS, Al-Majid AM, Ghabbour HA, Fun HK, Javed K, Imad R, Yousuf S, Choudhary MI, Wadood A..  (2015)  Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.,  23  (20): [PMID:26381063] [10.1016/j.bmc.2015.09.001]
117. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J..  (2015)  From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.,  23  (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007]
118. Ramadhan R, Phuwapraisirisan P..  (2015)  New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.,  25  (20): [PMID:26343830] [10.1016/j.bmcl.2015.08.069]
119. Javaid K, Saad SM, Rasheed S, Moin ST, Syed N, Fatima I, Salar U, Khan KM, Perveen S, Choudhary MI..  (2015)  2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.,  23  (23): [PMID:26552899] [10.1016/j.bmc.2015.10.038]
120. WHO Anatomical Therapeutic Chemical Classification, 
121. British National Formulary (72nd edition), 
122. Open TG-GATES,  [10.6019/CHEMBL3885861]
123. DrugMatrix,  [10.6019/CHEMBL3885881]
124. Unpublished dataset, 
125. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard.  (2020)  In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication,  [10.1101/2020.04.03.023846]
126. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
127. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson.  (2020)  Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2,  [10.1101/2020.04.21.054387]
128. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
129. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]
130. Sutherland JJ, Yonchev D, Fekete A, Urban L..  (2023)  A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.,  14  (1): [PMID:37468498] [10.1038/s41467-023-40064-9]